Michihiko Kuwano

St. Mary's Research Center
Kurume, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer.

Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer.

Journal: The Journal of biological chemistry

Published: April 11, 2025

Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial Cancer.

Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial Cancer.

Journal: The Kurume medical journal

Published: March 09, 2025

High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term Observation.

High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term Observation.

Journal: The Kurume medical journal

Published: November 27, 2024

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer.

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer.

Journal: Scientific reports

Published: May 16, 2024

Elevated expression of N-myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis.

Elevated expression of N-myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis.

Journal: Neuropathology : official journal of the Japanese Society of Neuropathology

Published: April 02, 2024

Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.

Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.

Journal: International journal of molecular sciences

Published: March 28, 2024

N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin.

N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin.

Journal: The Kurume medical journal

Published: October 04, 2023

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer.

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer.

Journal: Scientific reports

Published: January 22, 2022

Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.

Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.

Journal: Molecular cancer therapeutics

Published: July 12, 2019

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.

NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.

Journal: Communications biology

Published: March 18, 2019

Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.

Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.

Journal: Cancer research

Published: February 05, 2019

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.

Journal: Cancer science

Published: January 21, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026